Cargando…
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters
BACKGROUND: Psoriasis is a chronic inflammatory skin disease that can be successfully treated with a mixture of fumaric acid esters (FAE) formulated as enteric-coated tablets for oral use. These tablets consist of dimethylfumarate (DMF) and salts of monoethylfumarate (MEF) and its main bioactive met...
Autores principales: | Litjens, Nicolle HR, van Strijen, Elisabeth, van Gulpen, Co, Mattie, Herman, van Dissel, Jaap T, Thio, H Bing, Nibbering, Peter H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526253/ https://www.ncbi.nlm.nih.gov/pubmed/15479475 http://dx.doi.org/10.1186/1471-2210-4-22 |
Ejemplares similares
-
Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports
por: Balak, Deepak MW, et al.
Publicado: (2011) -
Maggot Secretions Skew Monocyte-Macrophage Differentiation Away from a Pro-Inflammatory to a Pro-Angiogenic Type
por: van der Plas, Mariena J. A., et al.
Publicado: (2009) -
Fumaric acid esters in dermatology
por: Wollina, Uwe
Publicado: (2011) -
Inflammatory and Antimicrobial Responses to Methicillin-Resistant Staphylococcus aureus in an In Vitro Wound Infection Model
por: Haisma, Elisabeth M., et al.
Publicado: (2013) -
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series
por: Balak, Deepak M.W., et al.
Publicado: (2016)